Sale of RISMA Systems A/S (DK) to Triple Private Equity (UK) TMT Sale of RISMA Systems A/S (DK) to Triple Private Equity (UK)
Placing of shares in Ambea AB (SE) — SEK 542 million Healthcare Placing of shares in Ambea AB (SE) — SEK 542 million
Placing of shares in Beijer Ref AB (SE) — SEK 3,140 million Business Services Placing of shares in Beijer Ref AB (SE) — SEK 3,140 million
Rights issue in Episurf Medical AB (SE) — SEK 30 million Healthcare Rights issue in Episurf Medical AB (SE) — SEK 30 million
Sale of Suomen Avustajapalvelut by CapMan to Verso Capital Healthcare Sale of Suomen Avustajapalvelut by CapMan to Verso Capital
Recommended public cash offer to the shareholders of Projektengagemang (SE) — SEK 361 million Business Services Recommended public cash offer to the shareholders of Projektengagemang (SE) — SEK 361 million
Sale of MatTek Corp (US) to Sartorius Lab Holding GmbH (DE) – USD 80 million Healthcare Sale of MatTek Corp (US) to Sartorius Lab Holding GmbH (DE) – USD 80 million
Rights issue in Bioretec Ltd. (FI) — EUR 9.2 million Healthcare Rights issue in Bioretec Ltd. (FI) — EUR 9.2 million
Senior non-preferred bonds by Hoist Finance AB (SE) – SEK 300 million FIG Senior non-preferred bonds by Hoist Finance AB (SE) – SEK 300 million
Rights issue in BrightBid Group AB (SE) — SEK 17.7 million TMT Rights issue in BrightBid Group AB (SE) — SEK 17.7 million
Directed share issue in Hansa Biopharma AB (SE) — SEK 232 million Healthcare Directed share issue in Hansa Biopharma AB (SE) — SEK 232 million
Recommended public cash offer to the shareholders of Fortnox AB (SE) — SEK 55 billion TMT Recommended public cash offer to the shareholders of Fortnox AB (SE) — SEK 55 billion